Acquired by ABP Acquisition LLC in Apr 2023
Company logo

ALR - AlerisLife Inc.

NASDAQ -> Healthcare -> Medical Care Facilities
Newton, United States
Type: Equity

ALR price evolution
ALR
(in millions $) 30 Oct 2022 30 Jul 2022 1 May 2022 31 Jan 2022
Current assets
Cash
Short term investments
Net receivables $66.17 $59.18 $58.13 $50.91
Inventory
Total current assets $199.32 $205.1 $211.63 $186.83
Long term investments
Property, plant & equipment $171.35 $169.8 $169.53 $172.51
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $382.54 $390.01 $396.47 $376.28
Current liabilities
Accounts payable $18.87 $18.18 $16.2 $41.4
Deferred revenue
Short long term debt
Total current liabilities $126.13 $121.35 $114.85 $140.91
Long term debt $69.51 $69.66 $69.59 $9.41
Total noncurrent liabilities
Total debt
Total liabilities $228.21 $227 $224.93 $194.69
Shareholders' equity
Retained earnings -$308.11 -$299.6 -$290.79 -$281.06
Other shareholder equity -$0.03 $0.25 $0.54 $1.03
Total shareholder equity
(in millions $) 31 Jan 2022 31 Jan 2021 31 Jan 2020 31 Jan 2019
Current assets
Cash
Short term investments
Net receivables $50.91 $105.46 $39.72 $45.61
Inventory
Total current assets $186.83 $262.31 $143.37 $138.05
Long term investments
Property, plant & equipment $172.51 $181.77 $188.1 $243.87
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $376.28 $454.21 $345.79 $405.62
Current liabilities
Accounts payable $41.4 $30.04 $2.25 $18.88
Deferred revenue
Short long term debt
Total current liabilities $140.91 $177.91 $164.3 $229.69
Long term debt $9.41 $10.7 $7.17 $7.53
Total noncurrent liabilities
Total debt
Total liabilities $194.69 $243.67 $225.81 $334.45
Shareholders' equity
Retained earnings -$281.06 -$251.14 -$245.18 -$292.64
Other shareholder equity $1.03 $1.32 $2.66 $1.74
Total shareholder equity
(in millions $) 30 Oct 2022 30 Jul 2022 1 May 2022 31 Jan 2022
Revenue
Total revenue $182.66 $171.12
Cost of revenue
Gross Profit $30.33 $29.15
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $36.06 $35.26
Operating income
Income from continuing operations
EBIT
Income tax expense $0.03 -$0.01
Interest expense -$1.67 -$2.17
Net income
Net income -$8.51 -$8.8
Income (for common shares)
(in millions $) 31 Jan 2022 31 Jan 2021 31 Jan 2020 31 Jan 2019
Revenue
Total revenue $1163.74 $1415.14 $1390.39
Cost of revenue
Gross Profit $183.08 $1101.35 $1109.55
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $167.14 $1117.49 $1187.77
Operating income
Income from continuing operations
EBIT
Income tax expense $0.66 $0.06 $0.25
Interest expense $0.03 -$0.24 -$2.79
Net income
Net income -$7.59 -$20 -$74.08
Income (for common shares)
(in millions $) 30 Oct 2022 30 Jul 2022 1 May 2022 31 Jan 2022
Net income
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$6.71 -$7.92 -$5.74 -$7.65
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing $59.85 $60.09 $60.04 -$1.44
Effect of exchange rate
Change in cash and equivalents $8.49 $13.4 $21.23 -$16.66
(in millions $) 31 Jan 2022 31 Jan 2021 31 Jan 2020 31 Jan 2019
Net income
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$7.65 $2.24 $62.98 $4.94
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing -$1.44 -$1.01 -$53.15 $50.96
Effect of exchange rate
Change in cash and equivalents -$16.66 $52.61 $5.72 $1.68
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding 32.61M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio 1.58
Quick ratio N/A